Literature DB >> 19098432

Epigenetics and cancer without genomic instability.

Elizabeth S McKenna1, Charles W M Roberts.   

Abstract

Genomic instability is often considered a hallmark of cancer. However, it remains unclear whether chromosomal disorganization is most frequently a cause or a consequence of tumorigenesis. The fact that subsets of many cancers lack chromosomal or microsatellite instability argues against the hypothesis that genomic instability plays an essential role in the initiation and maintenance of oncogenesis. Cancer-specific, epigenetically-based changes in gene expression caused by abnormalities in DNA methylation, in histone modifications, and in nucleosome positioning are gaining recognition as driving events in tumorigenesis. But are these changes merely a small piece of the oncogenesis puzzle or could they be the major component, or even sufficient for cancer? Here we discuss evidence that the progression of aggressive cancers can be driven by epigenetic events without genomic instability.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19098432     DOI: 10.4161/cc.8.1.7290

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  26 in total

1.  Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway.

Authors:  Zainab Jagani; E Lorena Mora-Blanco; Courtney G Sansam; Elizabeth S McKenna; Boris Wilson; Dongshu Chen; Justin Klekota; Pablo Tamayo; Phuong T L Nguyen; Michael Tolstorukov; Peter J Park; Yoon-Jae Cho; Kathy Hsiao; Silvia Buonamici; Scott L Pomeroy; Jill P Mesirov; Heinz Ruffner; Tewis Bouwmeester; Sarah J Luchansky; Joshua Murtie; Joseph F Kelleher; Markus Warmuth; William R Sellers; Charles W M Roberts; Marion Dorsch
Journal:  Nat Med       Date:  2010-11-14       Impact factor: 53.440

2.  Activation of β-catenin/TCF targets following loss of the tumor suppressor SNF5.

Authors:  E L Mora-Blanco; Y Mishina; E J Tillman; Y-J Cho; C S Thom; S L Pomeroy; W Shao; C W M Roberts
Journal:  Oncogene       Date:  2013-02-25       Impact factor: 9.867

3.  The chromatin regulator Brg1 suppresses formation of intraductal papillary mucinous neoplasm and pancreatic ductal adenocarcinoma.

Authors:  Guido von Figura; Akihisa Fukuda; Nilotpal Roy; Muluye E Liku; John P Morris Iv; Grace E Kim; Holger A Russ; Matthew A Firpo; Sean J Mulvihill; David W Dawson; Jorge Ferrer; William F Mueller; Anke Busch; Klemens J Hertel; Matthias Hebrok
Journal:  Nat Cell Biol       Date:  2014-02-23       Impact factor: 28.824

4.  Epigenetic inactivation of the tumor suppressor BIN1 drives proliferation of SNF5-deficient tumors.

Authors:  Elizabeth S McKenna; Pablo Tamayo; Yoon-Jae Cho; Erik J Tillman; E Lorena Mora-Blanco; Courtney G Sansam; Edward C Koellhoffer; Scott L Pomeroy; Charles W M Roberts
Journal:  Cell Cycle       Date:  2012-05-15       Impact factor: 4.534

Review 5.  Metal carcinogen exposure induces cancer stem cell-like property through epigenetic reprograming: A novel mechanism of metal carcinogenesis.

Authors:  Zhishan Wang; Chengfeng Yang
Journal:  Semin Cancer Biol       Date:  2019-01-11       Impact factor: 15.707

6.  microRNA-based cancer cell reprogramming technology.

Authors:  Shimpei Nishikawa; Hideshi Ishii; Naotsugu Haraguchi; Yoshihiro Kano; Takahito Fukusumi; Katsuya Ohta; Miyuki Ozaki; Dyah Laksmi Dewi; Daisuke Sakai; Taroh Satoh; Hiroaki Nagano; Yuichiro Doki; Masaki Mori
Journal:  Exp Ther Med       Date:  2012-04-23       Impact factor: 2.447

7.  Shorter telomere length in peripheral blood lymphocytes of workers exposed to polycyclic aromatic hydrocarbons.

Authors:  Sofia Pavanello; Angela-C Pesatori; Laura Dioni; Mirjam Hoxha; Valentina Bollati; Ewa Siwinska; Danuta Mielzyńska; Claudia Bolognesi; Pier-Alberto Bertazzi; Andrea Baccarelli
Journal:  Carcinogenesis       Date:  2009-11-05       Impact factor: 4.944

8.  Promoter hypermethylation of FBXO32, a novel TGF-beta/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer.

Authors:  Jian-Liang Chou; Her-Young Su; Lin-Yu Chen; Yu-Ping Liao; Corinna Hartman-Frey; Yi-Hui Lai; Hui-Wen Yang; Daniel E Deatherage; Chieh-Ti Kuo; Yi-Wen Huang; Pearlly S Yan; Shu-Huei Hsiao; Chien-Kuo Tai; Huey-Jen L Lin; Ramana V Davuluri; Tai-Kuang Chao; Kenneth P Nephew; Tim H-M Huang; Hung-Cheng Lai; Michael W-Y Chan
Journal:  Lab Invest       Date:  2010-01-11       Impact factor: 5.662

9.  Competing views on cancer.

Authors:  Carlos Sonnenschein; Ana M Soto; Annapoorni Rangarajan; Prakash Kulkarni
Journal:  J Biosci       Date:  2014-04       Impact factor: 1.826

Review 10.  The SWI/SNF tumor suppressor complex: Regulation of promoter nucleosomes and beyond.

Authors:  Ping Lu; Charles W M Roberts
Journal:  Nucleus       Date:  2013-09-30       Impact factor: 4.197

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.